Live from the NIH registry
Studies recruiting near Gulfport right now
Top 25 of 36 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Tekwani Vision Center — Bay Saint Louis, Mississippi (17.5 mi)
· Sponsor: Melt Pharmaceuticals
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
Lung Cancer Screening
N/A
Interventional 200 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Timothy Mullett
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: NRG Oncology
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 07 — D'Iberville, Mississippi (10.7 mi)
· Sponsor: TR Therapeutics
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ardelyx
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
SARS-CoV-2
Phase 4
Interventional 1,144 participants sought
Velocity Clinical Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: ModernaTX, Inc.
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Lung Cancer Diagnosis
N/A
Observational 20,000 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Freenome Holdings Inc.
Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Chronic Rhinitis
N/A
Interventional 30 participants sought
Bay Area ENT — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: Aventix Medical Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: AstraZeneca
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Respiratory Distress Syndrome, Acute
Phase 2
Interventional 52 participants sought
Ocean Springs Hospital — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: GEn1E Lifesciences
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
DelRicht Research at Gulfport Memorial — Gulfport, Mississippi (4.4 mi)
· Sponsor: Hoffmann-La Roche
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: United Therapeutics
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Singing River Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Stryker Instruments
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1068 — Gulfport, Mississippi (4.4 mi)
· Sponsor: Immunovant Sciences GmbH
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Hawthorne Health — Diamondhead, Mississippi (17.6 mi)
· Sponsor: Novo Nordisk A/S
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SoniVie Inc.
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 150 participants sought
MedPharmics, LLC — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
NeuroSpecs-Gulfport Performance Spine — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boston Scientific Corporation